Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era

BACKGROUND: Immunotherapy is currently being examined as a treatment modality for glioblastoma. Maintaining an optimal total lymphocyte count (TLC) after radiotherapy (RT) and using temozolomide may be beneficial in optimizing immunotherapy. However, conventional temozolomide-based chemoradiation is...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Hwa Kyung, Kim, Nalee, Yoon, Hong In, Kang, Seok-Gu, Kim, Se Hoon, Cho, Jaeho, Baek, Jong Geol, Chang, Jong Hee, Suh, Chang-Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436232/
https://www.ncbi.nlm.nih.gov/pubmed/30917849
http://dx.doi.org/10.1186/s13014-019-1256-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436232/
https://www.ncbi.nlm.nih.gov/pubmed/30917849
http://dx.doi.org/10.1186/s13014-019-1256-6

Ejemplares similares